Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy.

Siqueira RC, Costa RA, Scott IU, Cintra LP, Jorge R.

Acta Ophthalmol Scand. 2006 Dec;84(6):834-5. No abstract available.

2.

Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.

Spandau UH, Jonas JB.

Acta Ophthalmol Scand. 2007 May;85(3):340-1. No abstract available.

3.

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy.

Shaikh S.

Indian J Ophthalmol. 2008 May-Jun;56(3):259. No abstract available.

5.

Rapid regression of disc and retinal neovascularization in a case of Eales disease after intravitreal bevacizumab.

Kumar A, Sinha S.

Can J Ophthalmol. 2007 Apr;42(2):335-6. No abstract available.

PMID:
17392871
6.

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.

Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ, Wendel R, Patel A.

Ophthalmology. 2006 Oct;113(10):1695.e1-15.

PMID:
17011951
7.

Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.

Avery RL.

Retina. 2006 Mar;26(3):352-4. No abstract available.

PMID:
16508438
8.

Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy.

Mason JO 3rd, Nixon PA, White MF.

Am J Ophthalmol. 2006 Oct;142(4):685-8.

PMID:
17011869
9.

Resolution of subretinal haemorrhage and fluid after intravitreal bevacizumab in aggressive peripapillary subretinal neovascularization.

Soliman W, Lund-Andersen H, Larsen M.

Acta Ophthalmol Scand. 2006 Oct;84(5):707-8. No abstract available.

10.

Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial.

Mirshahi A, Roohipoor R, Lashay A, Mohammadi SF, Abdoallahi A, Faghihi H.

Eur J Ophthalmol. 2008 Mar-Apr;18(2):263-9.

PMID:
18320520
11.

Intravitreal bevacizumab (Avastin) for radiation retinopathy neovascularization.

Arriola-Villalobos P, Donate-López J, Calvo-González C, Reche-Frutos J, Alejandre-Alba N, Díaz-Valle D.

Acta Ophthalmol. 2008 Feb;86(1):115-6. Epub 2007 Aug 2. No abstract available.

12.

Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis.

Jorge R, Costa RA, Calucci D, Scott IU.

Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):1045-8. Epub 2006 Nov 29.

PMID:
17136357
13.

Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).

Jorge R, Costa RA, Calucci D, Cintra LP, Scott IU.

Retina. 2006 Nov-Dec;26(9):1006-13.

PMID:
17151487
14.

Intravitreal bevacizumab (Avastin) in proliferative diabetic retinopathy.

Minnella AM, Savastano CM, Ziccardi L, Scupola A, Falsini B, Balestrazzi E.

Acta Ophthalmol. 2008 Sep;86(6):683-7.

15.

Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.

Rishi P, Rishi E, Shroff D.

Indian J Ophthalmol. 2009 May-Jun;57(3):241-2. doi: 10.4103/0301-4738.49406. No abstract available.

16.

Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks.

Teixeira A, Moraes N, Farah ME, Bonomo PP.

Acta Ophthalmol Scand. 2006 Dec;84(6):835-6. No abstract available.

17.

Rapid regression of disc neovascularization in a patient with proliferative diabetic retinopathy following adjunctive intravitreal bevacizumab.

Bakri SJ, Donaldson MJ, Link TP.

Eye (Lond). 2006 Dec;20(12):1474-5. Epub 2006 May 5. No abstract available.

PMID:
16680105
19.

Intravitreal bevacizumab (Avastin) as a treatment of the neovascular complications of laser-induced chorioretinal anastomosis for nonischaemic central retinal vein occlusion.

Fong KC, Barry C, McAllister IL.

Clin Exp Ophthalmol. 2009 Jul;37(5):485-9. doi: 10.1111/j.1442-9071.2009.02063.x.

PMID:
19624345
20.

Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation.

Joeres S, Heussen FM, Treziak T, Bopp S, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1597-602. Epub 2007 Apr 17.

PMID:
17437123

Supplemental Content

Support Center